Daniel Bertholet - Investment Director

Daniel Bertholet
Investment Director

Daniel Bertholet is an Investment Director in the Life Sciences practice at Endeavour Vision, with a focus on medtech investments. Daniel has invested in PneumRx, Symetis, CeQur, Endoart (sold to Allergan), Thommen Medical (exited), Kuros Biosurgery, Novalar Pharmaceuticals (exited) and Neocutis. He also participated in investments and/or follow-on investments in Native Networks (sold to Alcatel), eProject/Daptiv (exited), Paion (IPO), Nexx Systems and Novimmune.

Prior to his venture capital career, Daniel was the co-founder and CFO of a technology start-up and has invested as a business angel/private investor in private companies for over 15 years in Europe and the US. Daniel started his career as a consultant in country risk assessment for Business Environment Risk Intelligence (BERI) in the US and Switzerland.

Daniel holds an MBA with honours from the Institut d’Etudes Politiques in Paris and a MA in International Political Economy from the American University in Washington DC.

Daniel enjoys wine tasting and skiing, and is personally committed to support vulnerable children in Sub-Saharan Africa. He lives in Geneva with his wife and their three young daughters.

tel.:	+41 22 544 6030
email.:
vcard:	open vcard

His favourite question to entrepreneurs: « What makes you passionate about your business? »

		"The partners have been very supportive of our approach and stepped in to add value when needed. I would strongly recommend them as investors." Didier Cowling, Founder and CEO, Kuros Biosurgery AG
		"In preparing for our dual IPOs on the Nasdaq and Neuer Markt, it was very important for SCM Microsystems to gain insight and access to the European investment scene. This team helped SCM build the foundation for our successful offerings not only with capital, but with sound guidance and value-added services as well." Robert Schneider, founder and CEO, SCM Microsystems Inc.
		"VC is about funding your project but it is more about extending your core team. Thus, it is about partnering with those who are great to work with and are team players. Those, who understand your business and embrace your vision. Those, who know how to challenge your execution and to bring value. This is why I recommend Endeavour Vision team to entrepreneurs looking for funding." Dr. Georges Karam, co-Founder, President & CEO, Sequans
		"With Endeavour Vision we have been able to establish at fast speed the personal trust level needed and also come to terms very quick. They are highly professional partners and support us in every possible manner." Christian Lindner, Co-Founder and CEO Retailo AG
		"The Endeavour Vision team have been much more supportive and additive than others I have worked with the past. When our company was spun-off from Danfoss incubator, they gave us a great amount of support in the administrative load of a start-up, and worked hard to learn the details of the market and opportunity. Consequently, they have supported our company tremendously over the years, from day-to-day operations to strategic direction." James Peterson, CEO and Vice-Chairman, CeQur SA
		"We wanted a Venture Capital investor who was prepared to share our vision to create a global European company. The quality of their track record, the way they are helping us take our company to the next level, and the pure scale of their ambition make them a pleasure to work with." Boris Saragaglia, CEO, Spartoo.com
		"Not only do Endeavour Vision partners demonstrate relentless long term support standing strong and reliable leading shareholders, but they also bring tremendous value by cross-fertilizing upcoming technologies if and when they make business sense." Claude Cosson, CEO, Perigee
		"Entrepreneurs tend to avoid as much as possible VC's but if you really need smart Venture money then put Endeavour Vision on the top of your list: they are smart, knowledgable, experienced and well connected." Fédéric Koehn, CEO, Neocutis
		"Endeavour Vision's team brought an in-depth knowledge of our field – highlighted by impressive and thorough 360° due diligence, the long-term perspective required to build substantial companies, outstanding experience of bringing venture to financial success and an uncommon sense for team work. This is "smart money" at its best." Jacques R. Essinger, CEO Symetis
		"The Endeavour Vision team has been very helpful to BIND on multiple levels. Their advice, contacts and support rank with the best." Scott Minick, CEO, BIND Biosciences